by Summary: Researchers have carried out clinical trials to test a mutation-specific vaccine against malignant brain tumors. The vaccine has been found to be safe and effective in triggering the desired immune response in the brain cancer tumors.Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients’ immune system to these mutated proteins. Neuroscience News - Mutation-Specific Brain Cancer Vaccine Tested
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
NewDealdemocrat writes Coronavirus dashboard, 4 years into the pandemic: all-time low in hospitalizations, deaths likely to follow
Angry Bear writes Tesla Is Not the Next Ford. It’s the Next Con Ed
Bill Haskell writes Nestlé adds sugar to baby food in low-income countries, report finds . . .
Lars Pålsson Syll writes Nu är det dags ta farväl av reformpedagogiken
Summary: Researchers have carried out clinical trials to test a mutation-specific vaccine against malignant brain tumors. The vaccine has been found to be safe and effective in triggering the desired immune response in the brain cancer tumors.
Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients’ immune system to these mutated proteins.
Neuroscience News - Mutation-Specific Brain Cancer Vaccine Tested